Baker Hughes (Waygate Technologies): Company Profile

Waygate Technologies: A $1.5B NDT Platform Seeking a New Owner as Baker Hughes Refocuses Capital

Baker Hughes is exploring a sale of Waygate Technologies, its nondestructive testing and industrial inspection division, at an estimated valuation of approximately $1.5 billion. The potential divestiture — reported by Bloomberg in February 2026 — reflects a deliberate capital reallocation by CEO Lorenzo Simonelli toward energy-transition platforms, not a distressed exit. For the NDT market, the transaction would be the most significant ownership change in the sector in years, and the outcome will shape investment trajectories across ultrasonic testing, computed tomography, and remote visual inspection for the next decade.

Business Overview

Waygate Technologies operates across 80+ countries as a consolidated NDT platform built from legacy brands accumulated over decades: Krautkrämer (ultrasonic testing), phoenix|x-ray (industrial CT and X-ray), Everest (remote visual inspection), Seifert (radiographic systems), and Agfa NDT. The entity was formally established as GE Inspection Technologies in 2004, absorbed into Baker Hughes following the 2017 GE Oil & Gas combination, and rebranded Waygate Technologies in 2020.

The underlying business is defensible. The question is whether new ownership can convert a well-positioned incumbent into a platform that competes on software and autonomy, not just hardware heritage.

No audited segment-level financials are publicly available. Baker Hughes reported consolidated Q3 2025 revenue of $7.0 billion with adjusted EBITDA of $1.238 billion, but Waygate's contribution is not separately disclosed. The $1.5 billion sale valuation is the primary public data point for sizing the business. MODERATE CONFIDENCE on all financial estimates.

The revenue model is hardware-led — instruments, scanners, and inspection systems — with recurring streams from service contracts, calibration, training, and equipment upgrades. Software and digital workflow tools are fielded but their contribution to total revenue is unverifiable from public sources.

Technology and Product Portfolio

Product Line	Brand	Platform	Deployment Status	Primary Environment
Ultrasonic testing (UT) devices	Krautkrämer	Handheld / mechanized	Fielded	Indoor
Industrial CT scanners	phoenix|x-ray	Fixed	Fielded	Indoor
Radiographic testing (X-ray) systems	Seifert / phoenix|x-ray	Fixed	Fielded	Indoor
Remote visual inspection (RVI)	Everest	Handheld / mechanized	Fielded	Indoor
Digital workflows and collaboration tools	Waygate platform	Software	Fielded	Indoor

All five product lines are operator-supervised. Semi-autonomous UT scanning with encoded crawlers and mechanized RVI systems represent the strongest robotics characterization in the portfolio, but full autonomous navigation or AI-driven defect recognition at scale is not substantiated in public sources. This is a meaningful gap relative to where the NDT market is heading: several competitors are advancing AI-assisted defect classification and self-navigating inspection platforms for confined spaces and elevated structures.

The digital workflow layer — remote collaboration, inspection planning, audit trails, ESG reporting — is the clearest near-term software monetization vector. Whether this translates to a subscription revenue model under current ownership or a future acquirer is unresolved.

Market Position

Waygate's competitive moat is rated WIDE based on three structural factors: brand trust accumulated over multiple decades in safety-critical, regulated industries; an installed base across 80+ countries generating high switching costs through service and calibration dependencies; and broad modality coverage across UT, RT/CT, and RVI that few single competitors replicate.

Regulatory tailwinds are durable. Aerospace additive manufacturing quality control, energy infrastructure integrity programs, and heavy industrial inspection mandates continuously drive equipment upgrade cycles independent of macroeconomic conditions. These are non-discretionary inspection requirements in most jurisdictions.

Primary competitive pressure comes from diversified test-and-measurement conglomerates and specialized NDT firms. Margin compression risk is real if Waygate's software differentiation remains limited relative to competitors investing more aggressively in AI-assisted analytics.

Outlook and Transaction Risk

The sale process, expected to commence in the months following the February 2026 Bloomberg report, is anticipated to draw private equity interest. A focused owner — PE or strategic — could unlock accelerated R&D investment, particularly in AI-assisted defect recognition and autonomous RVI, and position Waygate as a consolidation platform in a fragmented NDT market.

The risks are structural. Prolonged transaction uncertainty creates talent attrition exposure and potential customer hesitancy. Baker Hughes' parallel focus on integrating the $9.6 billion Chart Industries acquisition limits management bandwidth available to Waygate pre-close. And if no transaction materializes, Waygate remains in strategic limbo within a parent whose IET margin targets — 20% operating margin by 2026, 20% overall by 2028 — leave little room for non-core capital allocation.

The underlying business is defensible. The question is whether new ownership can convert a well-positioned incumbent into a platform that competes on software and autonomy, not just hardware heritage.